Keywords: zeltia, yondelis, enters, phase, iii, drug, major

Zeltia's Yondelis enters Phase III

Article | 09 April 2007

Print This

US drug major Wyeth has completed the purchase of the final 20% stake of Wyeth KK from Japanese drug major Takeda, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in